Haploidentical transplant, gene therapy, and standard care in sickle cell disease: a cost-effectiveness analysis.

Chetlapalli K, Ito S, Ng DQ, Sra M, Wang D, Krumholz HM, Krishnamurti L, Pandya A, Goshua G.

DOI: 10.1182/blood.2025032290
Published: 2026-08-01
Container: Blood
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/blood.2025032290,
  title = {Haploidentical transplant, gene therapy, and standard care in sickle cell disease: a cost-effectiveness analysis.},
  author = {Chetlapalli K and  Ito S and  Ng DQ and  Sra M and  Wang D and  Krumholz HM and  Krishnamurti L and  Pandya A and  Goshua G.},
  year = {2026},
  journal = {Blood},
  doi = {10.1182/blood.2025032290},
  url = {https://doi.org/10.1182/blood.2025032290}
}

RIS

TY  - JOUR
TI  - Haploidentical transplant, gene therapy, and standard care in sickle cell disease: a cost-effectiveness analysis.
AU  - Chetlapalli K
AU  -  Ito S
AU  -  Ng DQ
AU  -  Sra M
AU  -  Wang D
AU  -  Krumholz HM
AU  -  Krishnamurti L
AU  -  Pandya A
AU  -  Goshua G.
PY  - 2026
JO  - Blood
DO  - 10.1182/blood.2025032290
UR  - https://doi.org/10.1182/blood.2025032290
ER  -

APA

K, C., S, I., DQ, N., M, S., D, W., HM, K., L, K., A, P., & G., G. (2026). Haploidentical transplant, gene therapy, and standard care in sickle cell disease: a cost-effectiveness analysis.. Blood. https://doi.org/10.1182/blood.2025032290

Source records

europe-pmc · retrieved 2026-09-26T02:28:14.734Z